Lusutrombopag | CAS 1110766-97-6 - Request Quote
Lusutrombopag
| SZ CAT No: | SZ-L055001 |
| CAS No | 1110766-97-6 |
| Mol.F. | C29H32Cl2N2O5S |
| Mol.Wt. | 591.5 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lusutrombopag is chemically (S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid. Lusutrombopag is supplied with detailed characterization data compliant with regulatory guideline. Lusutrombopag can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lusutrombopag.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1110766-97-6
Purchase 1110766-97-6
Order 1110766-97-6
Enquire 1110766-97-6
price of 1110766-97-6
1110766-97-6 Supplier
1110766-97-6 Manufacturer
1110766-97-6 Exporter
buy high quality Lusutrombopag
Purchase Lusutrombopag
Lusutrombopag suppliers
Lusutrombopag manufacturers
Lusutrombopag price
Order Lusutrombopag
Enquire Lusutrombopag
Lusutrombopag cost
Lusutrombopag Supplier
Lusutrombopag Distributor
Lusutrombopag for Method Validation
Lusutrombopag Reference Standard
Lusutrombopag for ANDA Filing
Lusutrombopag for Forced Degradation Studies
Lusutrombopag Identification Standards
Lusutrombopag for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


